Principal Investigators

    Gehring, Kalle B


    McGill University

    Contact information of lead PI



    Title of project or programme

    Structural Studies of Parkinson's Disease

    Source of funding information


    Total sum awarded (Euro)

    € 645,278

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Parkinson's disease & PD-related disorders


    Research Abstract

    Parkinson’s disease (PD) is caused by the loss of dopamine producing neurons in region of the brain known as the substantia nigra. Recently, the study of genetic forms of PD has revealed the central role of damaged mitochondria in the death of neurons. These studies shown that the protein parkin, which is absent or mutated in many familial cases of PD, is required for the identification and recycling of damaged mitochondria. Parkin is a member of a large, diverse family of proteins called ubiquitin ligases. These proteins catalyze the attachment of a small protein, ubiquitin, to targeted proteins as a signal for the degradation of the target protein. We hypothesize that in a similar manner, parkin targets damaged mitochondria for degradation. In the absence of parkin, damaged mitochondria accumulate in neurons, which leads to neuronal dysfunction and ultimately cell death. Using structural biology, we propose to determine the three dimensional structure of parkin in order to determine how it functions to specifically target damaged mitochondria. Studies by ourselves and others have shown that parkin is recruited to cell membranes through a process that involves protein phosphorylation. We will determine the site of phosphorylation and the mechanism of activation of parkin’s ubiquitin-ligase activity. These studies will deepen our understanding of the quality control system that is responsible for maintaining health mitochondria and may lead to the development of novel therapeutic strategies for slowing the progression of PD or even preventing its occurrence in susceptible populations.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Canada
Diseases: Parkinson's disease & PD-related disorders
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF